Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
Мақола

AN INTRONIC POLYMORPHISM RS11773845 IN CAV1 GENE IS ASSOCIATED WITH THE RISK OF DEVELOPING ATRIAL FIBRILLATION IN UZBEK PATIENTS WITH ARTERIAL HYPERTENSION

Guzal AbdullaevaRepublican Specialized Scientific and Practical Medical Center of Cardiology, Tashkent, UZBEKISTANDarya ZakirovaGuliruh RadzhabovaRepublican Specialized Scientific and Practical Medical Center of Cardiology, Tashkent, UZBEKISTANNigora SherbadalovaRepublican Specialized Scientific and Practical Medical Center of Cardiology, Tashkent, UZBEKISTANMuazzam PulatovaRepublican Specialized Scientific and Practical Medical Center of Cardiology, Tashkent, UZBEKISTANZarina MashkurovaRepublican Specialized Scientific and Practical Medical Center of Cardiology, Tashkent, UZBEKISTANNodir IbrohimovRepublican Specialized Scientific and Practical Medical Center of Cardiology, Tashkent, UZBEKISTANА. А. Абдуллаев
Journal of Hypertensionjournal2024en
ABI

Аннотация

Objective: To determine the relationship of the rs11773845 polymorphism of the CAV1 gene with atrial fibrillation (AF) in patients with arterial hypertension (AH) in the Uzbek population. Design and method: The study included 154 patients with paroxysmal (n=47), persistent (n=21) and permanent (n=86) forms of AF. The control group (n=91) consisted of hypertensive patients without AF. The average age of hypertensive patients with AF was 65.2±10.8 years, and control group was 63.6±10.7 years. The diagnosis of AF was based on ECG and/or Holter ECG findings using standard diagnostic criteria. Genotyping of samples for carriage of allelic variants of the rs11264280 polymorphism was carried out using the RFLP-PCR method. Relative risk (OR) was calculated using genetic models. For all analyses, p values <0.05 were considered statistically significant. Results: Among hypertensive patients with AF, genotype of the rs11773845 polymorphism of the CAV1 gene was revealed: AA genotype - determined in 55 (35.7%) patients, AC genotype - in 80 (52.0%), CC genotype - 19 (12.3%), χ 2 =54.955, p=0.000. The allelic distribution showed a predominance of carriage of the A allele: A allele – 61.7%, C allele – 38.3%, χ 2 =33.662, p=1e-8. Among controls, on the contrary, the frequency of the C allele prevailed: 68.1% and 31.9% - the frequency of the A allele, χ 2 =47.868, p=0.000. The ratio of AA:AC:CC genotypes was as follows: 16.5%: 30.8%: 52.7%, (χ 2 =27.33, p=0.000) respectively. Based on the multiplicative model of inheritance, a significant accumulation of the A allele was demonstrated among 154 hypertensive patients with AF in 61.7% (χ 2 =40.70, p=0.000; OR=3.44, 95% CI 2.34-5.07), while the C allele was less common in 38.3% of cases. The dominant model of inheritance also demonstrated the association of AA + AC genotypes with the risk of developing AF in patients with AH, so AA + AC genotypes were more common in 87.7% (χ 2 = 47.01; p = 0.000; OR = 7.93, 95% CI 4.21-14.93) than CC genotype in 12.3% of cases. Conclusions: The AA+AC genotypes and the A allele of the rs11773845 polymorphism of CAV1 gene associated with risk of developing AF in Uzbek patients with AH.

Ҳали таржима қилинмаган

Мавзулар

Идентификаторлар

Иқтибослар ва манбалар

0 та иқтибос0 та фойдаланилган манба